Betsy Morrow

Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial

Ariel López-Chávez, Anish Thomas, Arun Rajan et al. · Journal of Clinical Oncology · 2015 · 234 citations

Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy

Raffit Hassan, Betsy Morrow, Anish Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 153 citations · Full text

Mutations of epigenetic regulatory genes are common in thymic carcinomas

Yisong Wang, Anish Thomas, Christopher Lau et al. · Scientific Reports · 2014 · 127 citations · Full text

Epigenetic Change, Genetics, Immunology +21

Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab

Swati Khanna, Anish Thomas, Daniel Abate‐Daga et al. · Journal of Thoracic Oncology · 2016 · 105 citations · Full text

Tumor Immunology, Pd-l1+ Tumor Cells, Cancer Immunosurveillance +10

A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in <i>PTEN</i>

Takefumi Komiya, Gideon M. Blumenthal, Roopa DeChowdhury et al. · The Oncologist · 2019 · 66 citations · Full text